Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeted radiotherapy chelates for in situ immune modulated cancer vaccination

Targeted radiotherapy chelates for in situ immune modulated cancer vaccination

US Patent 10751430 · Granted Aug 25, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Phospholipid ether analogs for imaging and targeted treatment of pediatric solid2025
Phospholipid ether analogs for imaging and targeted treatment of pediatric solid2025
PSMA-targeting ligands with optimal properties for imaging and therapy2025
PSMA-targeting ligands with optimal properties for imaging and therapy2024
Radiohalogenated agents for in situ immune modulated cancer vaccination2024
Radiohalogenated agents for in situ immune modulated cancer vaccination2024
Radiohalogenated agents for in situ immune modulated cancer vaccination2024
Radiohalogenated agents for in situ immune modulated cancer vaccination2024
Radiohalogenated agents for in situ immune modulated cancer vaccination2024
Radiohalogenated agents for in situ immune modulated cancer vaccination2024
Remote insect detector2024
Cationic cyclic amine and amphipathic transfection reagents2023